Wealthcare Advisory Partners’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-34
Closed -$4K – 909
2021
Q1
$4K Buy
+34
New +$3.69K ﹤0.01% 1697
2020
Q2
– Sell
-2
Closed – – 608
2020
Q1
$0 Hold
2
– – ﹤0.01% 1505
2019
Q4
$0 Hold
2
– – ﹤0.01% 1398
2019
Q3
$0 Hold
2
– – ﹤0.01% 1359
2019
Q2
$0 Sell
2
-2
-50% -$152 ﹤0.01% 1322
2019
Q1
$0 Sell
4
-3
-43% -$238 ﹤0.01% 1226
2018
Q4
$1K Hold
7
– – ﹤0.01% 1133
2018
Q3
$1K Hold
7
– – ﹤0.01% 1170
2018
Q2
$1K Hold
7
– – ﹤0.01% 1173
2018
Q1
$1K Sell
7
-540
-99% -$54.6K ﹤0.01% 1005
2017
Q4
$51K Hold
547
– – 0.01% 366
2017
Q3
$50K Buy
+547
New +$46.6K 0.01% 302

Other funds holding EMN

Wealthcare Advisory Partners's EMN Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Eastman Chemical (EMN) in Q2 2021, closing a stake of 34 shares — an estimated $4K sold.

Wealthcare Advisory Partners first reported a position in EMN in Q3 2017 and held it in 12 quarters. The position peaked at $51K in Q4 2017. 724 funds tracked by Wall St. Rank hold EMN as of Q2 2021.

  • Wealthcare Advisory Partners reported no remaining Eastman Chemical position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 34 Eastman Chemical shares in Q2 2021, an estimated $4K.
  • Wealthcare Advisory Partners first reported a position in Eastman Chemical in Q3 2017 and held it in 12 quarters.
  • Wealthcare Advisory Partners's Eastman Chemical position peaked at $51K in Q4 2017.
  • 724 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.